Study design & results
Available in the Gosset platform where reported.
Trial intelligence / Profile preview
Preliminary efficacy of Ophena (ospemifene) for vasomotor symptoms in menopause
2006-005071-17Phase 2Completed
- Sponsor
- Hormos Medical
- Start
- Oct 2006
- Modality
- Small Molecules
- Countries
- 1
01
Overview
Phase 2, randomised, double-blind trial in menopause and hot flash comparing Ophena 60 mg with Placebo (2 arms). Primary endpoints: Change in frequency of vasomotor symptoms and Safety and tolerability. Started Oct 2006; status: completed.
02
Drugs
ospemifene
03
Conditions
menopausehot flash
Beyond the preview
Go deeper on 2006-005071-17.
Study design, results and competitive context are available in the Gosset platform where reported.
Competitive context
Available in the Gosset platform where reported.
Bring the full picture into focus.
See how Gosset can support your research on 2006-005071-17.